Last update 04 Apr 2026

IRX-101

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
IRX 101, IRX101
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEye DiseasesOther Diseases
Active Indication
Corneal EdemaPainRetinal Diseases+ [1]
Inactive Indication
Diabetic macular oedemaGlaucoma, Angle-ClosureRetinal Vein Occlusion
Originator Organization
iRenix Medical, Inc.iRenix Medical, Inc.
Active Organization
iRenix Medical, Inc.iRenix Medical, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with IRX-101
NCT05750589
/ Not yet recruitingPhase 3
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Pain and Corneal Epitheliopathy
NCT05747430
/ RecruitingPhase 2
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Epitheliopathy
NCT05127525
/ TerminatedPhase 3
Randomized, Double-Masked, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of IRX-101 Versus 5% Povidone-Iodine as an Ocular Surface Sterilizer
100 Clinical Results associated with IRX-101
Login to view more data
100 Translational Medicine associated with IRX-101
Login to view more data
100 Patents (Medical) associated with IRX-101
Login to view more data
100 Deals associated with IRX-101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Corneal EdemaPhase 3
United States
iRenix Medical, Inc.iRenix Medical, Inc.
01 Sep 2026
PainPhase 3
United States
iRenix Medical, Inc.iRenix Medical, Inc.
01 Sep 2026
Retinal DiseasesPhase 3
United States
iRenix Medical, Inc.iRenix Medical, Inc.
01 Sep 2026
Diabetic macular oedemaPhase 3
United States
iRenix Medical, Inc.iRenix Medical, Inc.
15 Nov 2021
Glaucoma, Angle-ClosurePhase 3
United States
iRenix Medical, Inc.iRenix Medical, Inc.
15 Nov 2021
Retinal Vein OcclusionPhase 3
United States
iRenix Medical, Inc.iRenix Medical, Inc.
15 Nov 2021
Corneal endotheliolitisPhase 2
United States
iRenix Medical, Inc.iRenix Medical, Inc.
22 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free